[HTML][HTML] Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …
The related metabolic diseases and treatments of obesity
Obesity is a chronic disease characterized by the abnormal or excessive accumulation of
body fat, affecting more than 1 billion people worldwide. Obesity is commonly associated …
body fat, affecting more than 1 billion people worldwide. Obesity is commonly associated …
Non-alcoholic fatty liver disease and gut microbial dysbiosis-underlying mechanisms and gut microbiota mediated treatment strategies
M Jayachandran, S Qu - Reviews in Endocrine and Metabolic Disorders, 2023 - Springer
Non-alcoholic fatty liver disease (NAFLD) is by far the most prevalent form of liver disease
worldwide. It's also the leading cause of liver-related hospitalizations and deaths …
worldwide. It's also the leading cause of liver-related hospitalizations and deaths …
[HTML][HTML] Fatty liver & diabetes statistics in Korea: nationwide data 2009 to 2017
Methods This study analyzed data from the Korean National Health Insurance Service from
2009 to 2017 that included individuals aged 20 years or older who had undergone a …
2009 to 2017 that included individuals aged 20 years or older who had undergone a …
Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK/autophagy-mediated suppression of ER stress
SW Choi, W Cho, H Oh, AM Abd El-Aty, SA Hong… - Biochemical …, 2023 - Elsevier
Hepatic endoplasmic reticulum (ER) stress is a contributing factor in the development of
hepatic steatosis in obesity. Madecassoside (MA), a pentacyclic triterpene derived from …
hepatic steatosis in obesity. Madecassoside (MA), a pentacyclic triterpene derived from …
The impact and burden of dietary sugars on the liver
HE Huneault, AR Tovar… - Hepatology …, 2023 - journals.lww.com
NAFLD, or metabolic dysfunction–associated steatotic liver disease, has increased in
prevalence hand in hand with the rise in obesity and increased free sugars in the food …
prevalence hand in hand with the rise in obesity and increased free sugars in the food …
[HTML][HTML] Mitochondrial quality control: its role in metabolic dysfunction-associated steatotic liver disease (MASLD)
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-
alcoholic fatty liver disease, is characterized by hepatic steatosis and metabolic dysfunction …
alcoholic fatty liver disease, is characterized by hepatic steatosis and metabolic dysfunction …
[HTML][HTML] Lactobacillus Casei-fermented Amomum Xanthioides Mitigates non-alcoholic fatty liver disease in a high-fat diet mice model
Non-alcoholic fatty liver disease (NAFLD) is a substantial global health issue owing to its
high prevalence and the lack of effective therapies. Fermentation of medicinal herbs has …
high prevalence and the lack of effective therapies. Fermentation of medicinal herbs has …
Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Background A new fatty liver disease nomenclature, steatotic liver disease (SLD) has been
proposed; however, there are no data on clinical outcomes. We investigated the impact of …
proposed; however, there are no data on clinical outcomes. We investigated the impact of …
[HTML][HTML] Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study
BACKGROUND There is limited evidence regarding the association between muscle
strength and metabolic dysfunction-associated fatty liver disease (MAFLD). AIM To …
strength and metabolic dysfunction-associated fatty liver disease (MAFLD). AIM To …